Why the study?
Does transcatheter mitral valve-in-valve-in-valve replacement improve symptoms and valve hemodynamics in a patient with recurrent bioprosthetic mitral valve failure at high surgical risk?
Does transcatheter mitral valve-in-valve-in-valve replacement improve symptoms and valve hemodynamics in a patient with recurrent bioprosthetic mitral valve failure at high surgical risk?
Transcatheter mitral valve-in-valve-in-valve replacement is a feasible and effective strategy for managing recurrent bioprosthetic mitral valve failure in patients at high surgical risk.
No takes yet. Share an insight, caveat, or question.
May offer option for high-risk recurrent mitral bioprosthetic failure; hypothesis-generating case report requiring prospective validation.
Khan et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: